Core Viewpoint - Beijing Plant Doctor Cosmetics Co., Ltd. is set to go public on the Shenzhen Stock Exchange, showcasing its strong brand power built over 30 years through strategic focus, research, and market expansion [1] Group 1: Company Overview - The Plant Doctor brand was established in 1994 and has focused on the "highland plant skincare" sector, successfully creating iconic product lines such as "Dendrobium," "Purple Ganoderma," and "Cordyceps" [1] - The company has achieved stable revenue growth and continuous profit increase even during challenging industry periods from 2022 to 2024, demonstrating resilience through long-term dedication [1] Group 2: Research and Development - The company has a long-term partnership with the Kunming Institute of Botany, signing a 20-year strategic cooperation agreement in 2014, which has led to significant advancements in research [2] - A key achievement includes the extraction of high-activity Dendrobium oligosaccharides, which has been validated for its effectiveness in promoting collagen production, breaking the monopoly of international brands on high-end skincare ingredients [2] Group 3: Brand Philosophy and Social Responsibility - The brand embodies the philosophy of "respecting nature, valuing science, and giving back to society," collaborating with the UN Development Programme since 2021 on biodiversity and highland plant protection initiatives [3] - Initiatives include the establishment of a biodiversity experience garden and the "Wu Zhengyi Botany Award" to encourage scientific innovation, transforming short-term commercial actions into long-term value investments [3] - The brand's growth strategy integrates ecological protection and social responsibility, enhancing its brand value system and ensuring sustainable development [3]